Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Cancer Management and Research
|
November 22, 2021
AGTR1 Inhibits the Progression of Lung Adenocarcinoma
Lecai Xiong, Yanhong Wei, Xiao Zhou, et al.
Respiratory Research
|
May 15, 2026
Integrative bioinformatics and machine learning reveal an association of LTF and MMP8 with systemic inflammation and lung injury
Jutong He, Yanhong Wei, Yingjie Wu, et al.
Oncology Research
|
February 21, 2015
Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression
Hexiao Tang, Yongde Liao, Chao Zhang, et al.
Medical Oncology (Northwood, London, England)
|
March 7, 2015
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1
Changyu Liu, Yongde Liao, Sheng Fan, et al.
International Journal of Cancer
|
May 8, 2013
Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice
Hexiao Tang, Yongde Liao, Liqiang Xu, et al.
JTCVS Open
|
May 1, 2024
An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non-small cell lung cancer
Hexiao Tang, Eric Abston, Mozhdeh Sojoodi, et al.
Journal of Cellular Biochemistry
|
September 15, 2018
Interaction of estrogen receptor β5 and interleukin 6 receptor in the progression of non-small cell lung cancer
Hexiao Tang, Yuquan Bai, Lecai Xiong, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Cancer Management and Research
|
November 22, 2021
AGTR1 Inhibits the Progression of Lung Adenocarcinoma
Lecai Xiong, Yanhong Wei, Xiao Zhou, et al.
Respiratory Research
|
May 15, 2026
Integrative bioinformatics and machine learning reveal an association of LTF and MMP8 with systemic inflammation and lung injury
Jutong He, Yanhong Wei, Yingjie Wu, et al.
Oncology Research
|
February 21, 2015
Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression
Hexiao Tang, Yongde Liao, Chao Zhang, et al.
Medical Oncology (Northwood, London, England)
|
March 7, 2015
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1
Changyu Liu, Yongde Liao, Sheng Fan, et al.
International Journal of Cancer
|
May 8, 2013
Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice
Hexiao Tang, Yongde Liao, Liqiang Xu, et al.
JTCVS Open
|
May 1, 2024
An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non-small cell lung cancer
Hexiao Tang, Eric Abston, Mozhdeh Sojoodi, et al.
Journal of Cellular Biochemistry
|
September 15, 2018
Interaction of estrogen receptor β5 and interleukin 6 receptor in the progression of non-small cell lung cancer
Hexiao Tang, Yuquan Bai, Lecai Xiong, et al.
Page
of 4